Journal of General Virology, Vol 79, 2381-2391, Copyright © 1998 by Society for General Microbiology

ARTICLES

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

C Hultgren, DR Milich, O Weiland and M Sallberg
Division of Clinical Virology, Huddinge University Hospital, Sweden.

Ribavirin is effective in combination therapies against chronic hepatitis C virus (HCV) infection, although its direct antiviral properties are unclear. We therefore studied the immune-modulatory effects of ribavirin on hepatitis B virus (HBV)- and HCV-specific immune responses. During a 24 week placebo-controlled ribavirin trial in ten patients with chronic HCV infection, HCV antibodies and alanine aminotransferase (ALT) levels decreased transiently whereas the serum levels of HCV RNA remained stable. Effects of ribavirin on human and murine phytohaemagglutinin (PHA)-activated T cells included inhibition of in vitro proliferation and modulation of IL-2, IL-4, IFN-gamma and TNF-alpha levels. HBcAg- and HBeAg-specific IL-2 and IFN-gamma levels were > or = 25-fold higher in mice immunized with HBV core- or e- antigens (HBcAg, HBeAg) while receiving ribavirin compared to untreated mice, but IL-4 and IL-6 remained constant. Concordantly, a slight shift was observed in the IgG subclass distribution of the humoral responses of ribavirin-treated mice to HBeAg and HCV NS3 protein. Ribavirin treatment of HBeAg-transgenic (HBeAg-Tg) mice induced a dose-dependent down-regulation of T helper (Th)2-mediated antibody production to HBeAg. In ribavirin-treated HBeAg-Tg mice anti-HBe IgG1 (positively regulated by Th2 cytokines) decreased simultaneously as both anti-HBe IgG2a (positively regulated by Th1 cytokines) levels and in vitro T- cell IFN-gamma production increased, indicating a change in the Th1/Th2 balance. Thus, the present data suggest that ribavirin is not strictly an antiviral compound, but rather it alters the T-cell balance in the immune system.

This article has been cited by other articles:

				S. Chevaliez, R. Brillet, E. Lazaro, C. Hezode, and J.-M. Pawlotsky Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus Infection J. Virol., July 15, 2007; 81(14): 7732 - 7741. [Abstract] [Full Text] [PDF]

				A. A. Byrnes, D.-Y. Li, K. Park, D. Thompson, C. Mocilnikar, P. Mohan, J. P. Molleston, M. Narkewicz, H. Zhou, S. F. Wolf, et al. Modulation of the IL-12/IFN-{gamma} axis by IFN-{alpha} therapy for hepatitis C J. Leukoc. Biol., March 1, 2007; 81(3): 825 - 834. [Abstract] [Full Text] [PDF]

				K. Falasca, C. Ucciferri, M. Dalessandro, P. Zingariello, P. Mancino, C. Petrarca, E. Pizzigallo, P. Conti, and J. Vecchiet Cytokine Patterns Correlate with Liver Damage in Patients with Chronic Hepatitis B and C. Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 144 - 150. [Abstract] [Full Text] [PDF]

				M. Joo, Y. S. Hahn, M. Kwon, R. T. Sadikot, T. S. Blackwell, and J. W. Christman Hepatitis C Virus Core Protein Suppresses NF-{kappa}B Activation and Cyclooxygenase-2 Expression by Direct Interaction with I{kappa}B Kinase {beta} J. Virol., June 15, 2005; 79(12): 7648 - 7657. [Abstract] [Full Text] [PDF]

				S. Kaymakoglu, C. Karaca, K. Demir, S. Poturoglu, A. Danalioglu, S. Badur, M. Bozaci, F. Besisik, Y. Cakaloglu, and A. Okten Alpha Interferon and Ribavirin Combination Therapy of Chronic Hepatitis D Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1135 - 1138. [Abstract] [Full Text] [PDF]

				C. Carella, G. Mazziotti, G. Amato, L. E. Braverman, and E. Roti Interferon-{alpha}-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3656 - 3661. [Full Text] [PDF]

				D.-J. Chiang, Y.-L. Ye, W.-L. Chen, Y.-L. Lee, N.-Y. Hsu, and B.-L. Chiang Ribavirin or CpG DNA Sequence-Modulated Dendritic Cells Decrease the IgE Level and Airway Inflammation Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 575 - 580. [Abstract] [Full Text] [PDF]

				R. E. Lanford, B. Guerra, H. Lee, D. R. Averett, B. Pfeiffer, D. Chavez, L. Notvall, and C. Bigger Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons J. Virol., December 20, 2002; 77(2): 1092 - 1104. [Abstract] [Full Text] [PDF]

				M. V. Solbrig, R. Schlaberg, T. Briese, N. Horscroft, and W. I. Lipkin Neuroprotection and Reduced Proliferation of Microglia in Ribavirin-Treated Bornavirus-Infected Rats Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2287 - 2291. [Abstract] [Full Text] [PDF]

				E. Santagostino, M. G. Rumi, M. Rivi, M. Colombo, and P. M. Mannucci Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy Blood, February 1, 2002; 99(3): 1089 - 1091. [Abstract] [Full Text] [PDF]

				R. E. Lanford, D. Chavez, B. Guerra, J. Y. N. Lau, Z. Hong, K. M. Brasky, and B. Beames Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes J. Virol., September 1, 2001; 75(17): 8074 - 8081. [Abstract] [Full Text] [PDF]

				U. Lazdina, C. Hultgren, L. Frelin, M. Chen, K. Lodin, O. Weiland, G. Leroux-Roels, J. A. Quiroga, D. L. Peterson, D. R. Milich, et al. Humoral and CD4+ T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein J. Gen. Virol., June 1, 2001; 82(6): 1299 - 1308. [Abstract] [Full Text]

				R. C. Tam, K. Ramasamy, J. Bard, B. Pai, C. Lim, and D. R. Averett The Ribavirin Analog ICN 17261 Demonstrates Reduced Toxicity and Antiviral Effects with Retention of both Immunomodulatory Activity and Reduction of Hepatitis-Induced Serum Alanine Aminotransferase Levels Antimicrob. Agents Chemother., May 1, 2000; 44(5): 1276 - 1283. [Abstract] [Full Text]

				P. Leyssen, E. De Clercq, and J. Neyts Perspectives for the Treatment of Infections with Flaviviridae Clin. Microbiol. Rev., January 1, 2000; 13(1): 67 - 82. [Abstract] [Full Text] [PDF]

				I. Jordan, T. Briese, D. R. Averett, and W. I. Lipkin Inhibition of Borna Disease Virus Replication by Ribavirin J. Virol., September 1, 1999; 73(9): 7903 - 7906. [Abstract] [Full Text]